VAISHALI PHARMA Financial Statement Analysis
|
||
|
The Revenues of VAISHALI PHARMA have increased by 14.77% YoY .
The Earnings Per Share (EPS) of VAISHALI PHARMA has decreased by -91.04 % YoY. |
||
VAISHALI PHARMA Last 5 Annual Financial Results
[NSE : VAISHALI]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹99 Cr | ₹86 Cr | ₹70 Cr | ₹76 Cr | ₹54 Cr |
| Expenses | ₹98 Cr | ₹85 Cr | ₹60 Cr | ₹69 Cr | ₹51 Cr |
| Operating Profit (Excl OI) | ₹0.57 Cr | ₹1.67 Cr | ₹9.38 Cr | ₹6.89 Cr | ₹2.65 Cr |
| Other Income | ₹3.21 Cr | ₹2.03 Cr | ₹2.23 Cr | ₹1.79 Cr | ₹1.81 Cr |
| Interest | ₹2.07 Cr | ₹2.27 Cr | ₹2.26 Cr | ₹2.49 Cr | ₹2.63 Cr |
| Depreciation | ₹0.49 Cr | ₹0.51 Cr | ₹0.50 Cr | ₹0.46 Cr | ₹0.43 Cr |
| Profit Before Tax | ₹1.23 Cr | ₹0.93 Cr | ₹8.85 Cr | ₹5.73 Cr | ₹1.41 Cr |
| Profit After Tax | ₹0.82 Cr | ₹0.72 Cr | ₹6.60 Cr | ₹4.02 Cr | ₹1.05 Cr |
| Earnings Per Share (Rs) | ₹0.06 | ₹0.67 | ₹6.26 | ₹3.82 | ₹0.99 |
| PAT Margin (%) | 0.83 | 0.83 | 9.48 | 5.31 | 1.95 |
| ROE(%) | 1.62 | 2.09 | 22.26 | 16.50 | 4.78 |
| ROCE(%) | 4.99 | 5.82 | 21.92 | 18.87 | 10.33 |
| Total Debt/Equity(x) | 0.18 | 0.35 | 0.41 | 0.79 | 0.78 |
Key Financials |
||
| Market Cap | : | ₹ 78.0 Cr |
| Revenue (TTM) | : | ₹ 114.1 Cr |
| Net Profit(TTM) | : | ₹ -0.5 Cr |
| EPS (TTM) | : | ₹ 0.0 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VAISHALI PHARMA | -0.2% | -23.8% | -52.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.3% | 3.1% | 2.2% |
| DIVIS LABORATORIES | 0.5% | -2.9% | 5.4% |
| CIPLA | -3.3% | -6.9% | -17% |
| TORRENT PHARMACEUTICALS | 0.1% | 1.4% | 37.6% |
| DR REDDYS LABORATORIES | 1.9% | 1.4% | 10.7% |
| MANKIND PHARMA | -4.4% | -3.6% | -7.9% |
| ZYDUS LIFESCIENCES | 0.5% | -2.1% | -1.9% |
| LUPIN | 1.4% | 4.3% | 13.2% |
VAISHALI PHARMA Revenues
[NSE : VAISHALI]
| Y-o-Y | 14.77 % |
| 5 Yr CAGR | 16.49 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹99 Cr | 14.77 | |
| Mar2024 | ₹86 Cr | 23.85 | |
| Mar2023 | ₹70 Cr | -8.12 | |
| Mar2022 | ₹76 Cr | 41.00 | |
| Mar2021 | ₹54 Cr | - | |
VAISHALI PHARMA Operating Profit
[NSE : VAISHALI]
| Y-o-Y | -65.59 % |
| 5 Yr CAGR | -31.77 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.57 Cr | -65.59 | |
| Mar2024 | ₹1.67 Cr | -82.21 | |
| Mar2023 | ₹9.38 Cr | 36.21 | |
| Mar2022 | ₹6.89 Cr | 160.01 | |
| Mar2021 | ₹2.65 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -69.95 % |
| 5 Yr CAGR | -41.40 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 0.58% | -69.95 | |
| Mar2024 | 1.93% | -85.66 | |
| Mar2023 | 13.46% | 48.24 | |
| Mar2022 | 9.08% | 84.55 | |
| Mar2021 | 4.92% | - | |
VAISHALI PHARMA Profit After Tax
[NSE : VAISHALI]
| Y-o-Y | 13.63 % |
| 5 Yr CAGR | -5.99 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.82 Cr | 13.63 | |
| Mar2024 | ₹0.72 Cr | -89.11 | |
| Mar2023 | ₹6.60 Cr | 64.12 | |
| Mar2022 | ₹4.02 Cr | 284.70 | |
| Mar2021 | ₹1.05 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.00 % |
| 5 Yr CAGR | -19.23 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 0.83 % | 0.00 | |
| Mar2024 | 0.83 % | -91.24 | |
| Mar2023 | 9.48 % | 78.53 | |
| Mar2022 | 5.31 % | 172.31 | |
| Mar2021 | 1.95 % | - | |
VAISHALI PHARMA Earnings Per Share (EPS)
[NSE : VAISHALI]
| Y-o-Y | -91.04 % |
| 5 Yr CAGR | -50.38 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.06 | -91.04 | |
| Mar2024 | ₹0.67 | -89.30 | |
| Mar2023 | ₹6.26 | 63.87 | |
| Mar2022 | ₹3.82 | 285.86 | |
| Mar2021 | ₹0.99 | - | |
VAISHALI PHARMA Return on Capital Employed (ROCE)
[NSE : VAISHALI]
| Y-o-Y | -14.26 % |
| 5 Yr CAGR | -16.63 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 4.99% | -14.26 | |
| Mar2024 | 5.82% | -73.45 | |
| Mar2023 | 21.92% | 16.16 | |
| Mar2022 | 18.87% | 82.67 | |
| Mar2021 | 10.33% | - | |
VAISHALI PHARMA Share Price vs Sensex
| Current Share Price | : | ₹6.0 |
| Current MarketCap | : | ₹ 78.0 Cr |
| Updated EOD on | : | Mar 20,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -0.2% |
-23.8% |
-52.3% |
| SENSEX | -0% |
-10.7% |
1% |
VAISHALI PHARMA related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about VAISHALI PHARMA Financials
How the annual revenues of VAISHALI PHARMA have changed ?
The Revenues of VAISHALI PHARMA have increased by 14.77% YoY .
How the Earnings per Share (EPS) of VAISHALI PHARMA have changed?
The Earnings Per Share (EPS) of VAISHALI PHARMA has decreased by -91.04 % YoY .
Check out Intrinsic Value of Peers of VAISHALI PHARMA
Compare Stock Analytics of Peers of VAISHALI PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
